Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$799K Sell
2,272
-84
-4% -$29.9K 0.12% 105
2025
Q4
$771K Sell
2,356
-1,239
-34% -$393K 0.1% 105
2025
Q3
$1.01M Sell
3,595
-47
-1% -$13.6K 0.13% 100
2025
Q2
$1.02M Buy
+3,642
New +$1.03M 0.15% 103

Other funds holding AMGN

S-Bank Fund Management's AMGN Position: Q1 2026 in Review

S-Bank Fund Management reduced its Amgen (AMGN) stake by 3.6% in Q1 2026, selling an estimated $29.9K and leaving 2,272 shares worth $799K. The position accounts for 0.12% of the portfolio, ranked #105.

S-Bank Fund Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.02M in Q2 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • S-Bank Fund Management held 2,272 shares of Amgen worth $799K as of Q1 2026.
  • S-Bank Fund Management sold 84 Amgen shares in Q1 2026, an estimated $29.9K.
  • Amgen made up 0.12% of S-Bank Fund Management's portfolio in Q1 2026, its #105 holding.
  • S-Bank Fund Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • S-Bank Fund Management's Amgen position peaked at $1.02M in Q2 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on S-Bank Fund Management's 13F filing for Q1 2026, filed 11 May 2026.